It looks like Clarus Ventures is planning to reload with investment capital for life science companies.
The Boston- and San Francisco-based venture firm revealed in a SEC filing it’s looking to raise up to $375 million for a third fund.
Clarus invests mainly in biotech, with a few medtech and diagnostics companies in the mix.
Image: http://medcitynews.com
To read the original article: Bicoastal life science VC aims for $375 million third fund
